SAT-LB002 Steroid Metabolome Analysis Reveals 11-Ketotestosterone as the Most Abundant Androgen in Castration-Resistant Prostate Cancer Patients on Second-Line Therapies

Introduction Metastatic castration-resistant prostate cancer (CRPC) remains a clinical challenge despite antitumoral therapies such as taxane chemotherapeutics, enzalutamide, and abiraterone acetate. Clinical studies have highlighted the benefits of these therapies on overall and progression-free su...

Descripción completa

Detalles Bibliográficos
Autores principales: Snaterse, Gido, van Dessel, Lisanne, Taylor, Angela, Visser, Jenny, Arlt, Wiebke, Lolkema, Martijn, Hofland, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Steroid Hormones and Receptors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551668/
http://dx.doi.org/10.1210/js.2019-SAT-LB002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551668/
http://dx.doi.org/10.1210/js.2019-SAT-LB002

Ejemplares similares